E2F8 and ovarian serous adenocarcinoma: A similar trend was found for E2F8 in Lu's (28) and TCGA datasets: the mRNA levels of E2F8 in ovarian serous adenocarcinoma (fold change = 1.771 and p–value = 6.04E-05) and ovarian serous carcinoma (fold change = 3.136 and p–value = 7.97E-06) were significantly higher than those in the normal samples.